Status:
UNKNOWN
Pre- and Postoperative Probiotics Administration in Patients Undergoing Sleeve Gastrectomy
Lead Sponsor:
Hospital General Universitario Elche
Conditions:
Weight Loss
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
Patients will be randomized into 2 groups: * G1: Patients undergoing sleeve gastrectomy as bariatric procedure and receiving pre- and postoperative probiotics * G2: Patients undergoing sleeve gastrec...
Detailed Description
Patients will be randomized into 2 groups: * G1: Patients undergoing sleeve gastrectomy as bariatric procedure and receiving pre- and postoperative probiotics * G2: Patients undergoing sleeve gastrec...
Eligibility Criteria
Inclusion
- BMI \>40
- BMI \>35 associated to diabetes mellitus, hypertension, dyslipidemia or sleep apnea/hypopnea síndrome
- Patients undergoing laparoscopic sleeve gastrectomy as primary bariatric procedure
Exclusion
- Revisional surgery
- Patients with gastroesophageal reflux disease
- Patients planned for a sleeve gastrectomy as first step of a second malabsorptive procedure
- Patients with immune deficiencies or with chronic intake of immune supressor drugs
- patients refusing to participate in the study
Key Trial Info
Start Date :
May 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04367428
Start Date
May 2 2020
End Date
July 31 2021
Last Update
April 29 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.